Cost-effectiveness of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, versus methotrexate in patients with rheumatoid arthritis using real-world data from the IORRA observational cohort study
2015 ◽
Vol 25
(4)
◽
pp. 503-513
◽
2018 ◽
Keyword(s):
2016 ◽
Vol 27
(2)
◽
pp. 227-236
◽
Keyword(s):
2017 ◽
Keyword(s):
2018 ◽
2006 ◽
Vol 65
(1)
◽
pp. 20-25
◽